Found 79 All Conditions trials

Below is a list of actively recruiting clinical trials based on your search for "All Conditions"

Program with 2 clinical trials
An investigational medication is what is being studied to see if symptoms improve while taking it. It is not yet approved for general use by regulatory authorities. This study uses an investigational medication called Riliprubart. The investigational medicine is injected in a vein or under the skin, either at the …
Program with 2 clinical trials
These clinical studies are investigating the safety and efficacy of an investigational medication for patients with moderate to severe COPD and who are either current smokers or have a history of smoking.
18 years or above
All genders
Phase 3
Interventional
This study investigates the effectiveness, safety, and how the body processes an investigational medication compared to a placebo in adults with warm autoimmune hemolytic anemia (wAIHA). Participants in the study are 18 years and older, with a confirmed diagnosis of primary wAIHA.Participants will be randomly assigned to one of two …
18 years or above
All genders
Phase 3
Interventional
This study investigates the use of an investigational medication compared to a placebo in adults diagnosed with IgG4-related Disease (IgG4-RD). The purpose of this study is to evaluate the effectiveness and safety of the investigational medication over a 52-week period, focusing on the time to disease flare and other important …
18 years - 80 years
All genders
Phase 2
Interventional
This study investigates the effects of an investigational medication compared to a placebo in adults with high-risk asthma. This study aims to evaluate the effectiveness, safety, and comfort of using the investigational medication as an additional treatment for asthma in participants who are not currently eligible for biologic treatments.Participants will …
18 years - 75 years
All genders
Phase 2
Interventional
This study investigates the effects of an investigational medication on adults with moderate to severe Crohn's Disease (CD). The purpose of this study is to compare different doses of the investigational medication with a placebo to assess their effectiveness and safety.Participants will be randomly assigned to receive either the investigational …
18 years - 75 years
All genders
Phase 2
Interventional
This study investigates the efficacy and safety of an investigational medication in adults with moderate-to-severe ulcerative colitis (UC). The study aims to assess if different doses of the investigational medication can achieve clinical remission in participants with this condition.Participants will undergo various procedures, including a screening period, a double-blind treatment …
12 years - 35 years
All genders
Phase 2
Interventional
This study investigates the effect of an investigational medication on preserving insulin secretion in individuals with Type 1 diabetes (T1D). The study compares three dose levels of the investigational medication with a placebo in adults and adolescents who have recently been diagnosed with T1D and are on insulin therapy.Participants will …
1 year - 25 years
All genders
Phase 3
Interventional
The purpose of this study is to evaluate the effectiveness and safety of an investigational medication compared to a placebo in individuals aged 1 to 25 years with Stage 3 Type 1 diabetes.Participants will receive either the investigational medication or a placebo through intravenous (IV) infusion. A placebo is an …
18 years - 75 years
All genders
Phase 2
Interventional
This study investigates the effectiveness and safety of an investigational medication in treating adults with moderate to severe Ulcerative Colitis. The study will compare different doses of the investigational medication to a placebo to see which works best.Participants will be randomly assigned to one of three study arms. They will …
1 - 10 of 79